InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by DeLucia David. Director active across 2 companies, notably FIBROGEN INC. Cumulatively, 6 disclosures have been recorded. History available since 6 March 2025. The latest transaction was filed on 6 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
DeLucia David is a declarant linked to FIBROGEN INC and KYNTRA BIO, INC., where he is Chief Financial Officer. The record shows 5 filings in total, and the 5 sampled filings, between 2025-03-07 and 2026-06-09, show 0 in purchases and 0 in sales, with transactions described as tax withholding.